Trials / Completed
CompletedNCT04196673
Posterior Capsule Opafication of Two Different Hydrophobic Acrylic Intraocular Lenses
Posterior Capsule Opafication of Two Different Hydrophobic Acrylic Intraocular Lenses: Vivinex iSert P261 vs. Acrysof SN60WF
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 50 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
On the day of surgery, the first eye to be operated is randomised to receive a Vivinex , HOYA Surgical Optics GmbH or an SN60WF, Alcon, Fort Worth, Texas. The second eye to be operated receives the other IOL type. A complete biomicroscopic examination, visual acuity testing using autorefractometer, contrast sensitivity testing, and standardised retroillumination photography for PCO evaluation, will be performed 6 month (30-60 days), 1.5 years (± 3 months) and 3 (± 3 months) years postoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Alcon SN60WF | Implantation of an intraocular lens Alcon SN60WF |
| DEVICE | Hoya Vivinex | Implantation of an intraocular lens Hoya Vivinex |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-06-19
- Completion
- 2019-08-23
- First posted
- 2019-12-12
- Last updated
- 2019-12-12
Source: ClinicalTrials.gov record NCT04196673. Inclusion in this directory is not an endorsement.